Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead
Co-Diagnostics shares soared 206% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests in Saudi Arabia and 18 other countries. Over 100 million shares traded amid the surge. The stock’s market cap jumped from about $18 million to as much as $60 million. The company reported just $200,000 in Q2 revenue and recently raised $3.8 million via stock sale.